Is Donald Trump the Drug President?
Summary
President Donald Trump signed executive orders to speed up the approval of psychedelic drugs and to reclassify marijuana to a less restrictive category. These moves mark significant changes in U.S. drug policy, making some controlled substances easier to access medically while still maintaining strict law enforcement against drug trafficking.Key Facts
- On April 18, President Trump signed an order to fast-track the approval of psychedelic drugs like psilocybin and LSD derivatives.
- Four months earlier, he ordered marijuana to be moved from Schedule I to Schedule III, lowering its restriction level.
- Schedule I drugs are seen as highly addictive with no accepted medical use; Schedule III drugs have lower risk and some medical use.
- Rescheduling marijuana allows cannabis businesses to deduct standard expenses on federal taxes.
- Despite these changes, marijuana products still require FDA approval and a prescription to be legally available.
- President Trump's actions are faster and more direct than previous presidents' drug policy changes.
- His administration also increased enforcement against fentanyl use and cut funding for addiction treatment programs.
- Experts describe the policy as a mix of more medical access and strong drug enforcement efforts.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.